A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis.
Completed · Phase 1
Conditions studied: Rheumatoid Arthritis
In brief
This 2 arm study will investigate the pharmacokinetics of simvastatin and methotrexate in combination with tocilizumab to assess any potential drug interactions. Patients will be randomized to receive either tocilizumab (10mg/kg iv infusion on day 8) + methotrexate (10-25mg po /week) or tocilizumab + methotrexate + simvastatin (40mg po on days 1, 15 and 43). Blood samples will be taken for analysis at intervals up to day 44. The anticipated time on study treatment is \<3 months, and the target sample size is \<100 individuals.
Key facts
- Study ID
- NCT00365001
- Run by
- Hoffmann-La Roche
- People needed
- 23
- Expected to finish
- 2008-04-01
- Last updated by the study team
- 2010-06-11
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- adult patients, 18-75 years of age;
- rheumatoid arthritis for >=6 months;
- methotrexate for >=12 weeks prior to day 1 (stable at 10-25mg/week for 8 weeks).
You may not qualify if…
- history of, or current inflammatory joint disease or rheumatic autoimmune disease other than RA;
- concurrent treatment with any DMARD other than methotrexate;
- prior treatment with tocilizumab.
Where it is running
- Study site — Anniston, Alabama, United States
- Study site — Scottsdale, Arizona, United States
- Study site — Little Rock, Arkansas, United States
- Study site — Jacksonville, Florida, United States
- Study site — Palm Harbor, Florida, United States
- Study site — Royal Oak, Michigan, United States
- Study site — Omaha, Nebraska, United States
- Study site — Oklahoma City, Oklahoma, United States
- Study site — Duncansville, Pennsylvania, United States
- Study site — Austin, Texas, United States
- Study site — Christchurch, New Zealand
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.